As Canada’s flu season collides with record strep A cases and ongoing COVID-19 concerns, a new study is shedding light on our understanding of respiratory immune responses. Scholars from the Research Institute of the McGill University Health Centre (RI-MUHC) have discovered a surprising facet about a century-old vaccine for tuberculosis, Bacillus Calmette Guérin (BCG).

Classified as: Kim Tran, Maziar Divangahi, McGill University Health Centre (RI-MUHC), Department of Medicine
Category:
Published on: 22 Feb 2024

Every day, humans breathe in 11,000 litres of air. But this essential act also means we inhale microorganisms, particles, and pollutants. A new study from the Research Institute of the McGill University Health Centre (RI-MUHC) has revealed how the unique immune cells that are developed in the embryo protect our lungs from environmental challenges throughout the course of our lifetime.

Classified as: Maziar Divangahi, McGill University Health Centre (RI-MUHC)
Category:
Published on: 2 Feb 2023

For most people, the influenza A virus (IAV), commonly known as the flu, is cleared from the body by our own immune system. In some cases, however, the immune response becomes dysregulated and if left uncontrolled, the inflammation caused by our own immune cells can lead to extensive lung tissue damage and enhanced morbidity and mortality.

How can we help our immune system to balance the two main host defense strategies: attacking pathogens (called host resistance) and preserving our own tissue (called disease tolerance)?

Classified as: influenza, host resistance, Maziar Divangahi, RI-MUHC, Erwan Pernet
Category:
Published on: 22 May 2019

Current treatments for tuberculosis (TB) are very effective in controlling TB infection caused by Mycobacterium tuberculosis (Mtb). They don’t, however, always prevent reinfection. Why this happens is one of the long-standing questions in TB research.

Classified as: Mycobacterium tuberculosis, Irah King, Maziar Divangahi, Research Institute of the McGill University Health Centre, Macdonald Campus, gut microbiota
Category:
Published on: 22 Mar 2019

Historically, our view of host defense against infection was that we must eliminate pathogens to eradicate disease. However, this perspective has recently been challenged as scientists have taken a lesson from plant biologists about an ancient strategy involving the ability to “tolerate” rather than “resist” infection to maintain health. This concept, referred to as “disease tolerance”, provides an opportunity to develop new strategies that mitigate the consequences of infection.

Classified as: tuberculosis, cyclophilin D, CypD, Maziar Divangahi
Category:
Published on: 11 May 2018

Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States during the current flu season. Aside from getting the flu shot and employing smart hand hygiene, there are no other methods of prevention. However, a team of scientists from the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University, led by Immunologist Dr.

Classified as: Flu, muhc, Maziar Divangahi, McGill, flu season, Research Institute of the McGill University Health Centre (RI-MUHC)
Category:
Published on: 14 Feb 2018
Back to top